P872: EFFICACY OF DARATUMUMAB PLUS BORTEZOMIB, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH MULTIPLE MYELOMA PRESENTING WITH EXTRAMEDULLARY DISEASE: A EUROPEAN MYELOMA NETWORK STUDY (EMN19)

• Meral Beksac,
• Tulin Tuglular,
• Francesca Gay,
• Roberto Mina,
• Eirini Katodritou,
• Ali Unal,
• Michele Cavo,
• Guner Hayri Ozsan,
• Vincent H.J. van der Velden,
• Berna Beverloo,
• Michael Vermeulen,
• Mark van Duin,
• Guldane Cengiz,
• Omur Gokmen Sevindik,
• Serena Merante,
• Kyriaki Manousou,
• Pieter Sonneveld,
• Evangelos Terpos

Affiliations

Meral Beksac

1 Department of Hematology, Ankara University Faculty Of Medicine Cebeci Hospital, Ankara, Turkey

Tulin Tuglular

2 Department of Internal Medicine, Marmara University, Istanbul, Turkey

Francesca Gay

3 University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy

Roberto Mina

3 University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy

Eirini Katodritou

4 Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece, Thessaloniki, Greece

Ali Unal

5 Department of Hematology, Faculty of Medicine, Erciyes University, Melikgazi, Kayseri, Turkey

Michele Cavo

6 Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy

Guner Hayri Ozsan

7 Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Dokuz Eylul University, Izmir, Turkey

Vincent H.J. van der Velden

8 Erasmus MC, University Medical Center Rotterdam, Department of Immunology, Rotterdam, Netherlands

Berna Beverloo

9 Erasmus MC, University Medical Center Rotterdam, Department of Clinical Genetics, Rotterdam, Netherlands

Michael Vermeulen

10 Erasmus MC, University Medical Center Rotterdam, Department of Hematology, Rotterdam, Netherlands

Mark van Duin

10 Erasmus MC, University Medical Center Rotterdam, Department of Hematology, Rotterdam, Netherlands

Guldane Cengiz

1 Department of Hematology, Ankara University Faculty Of Medicine Cebeci Hospital, Ankara, Turkey

Omur Gokmen Sevindik

1 Department of Hematology, Ankara University Faculty Of Medicine Cebeci Hospital, Ankara, Turkey

Serena Merante

11 European Myeloma Network, Pavia, Italy

Kyriaki Manousou

12 Health Data Specialists, Dublin, Ireland

Pieter Sonneveld

10 Erasmus MC, University Medical Center Rotterdam, Department of Hematology, Rotterdam, Netherlands

Evangelos Terpos

13 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece